Peptides: what a pharmacist actually thinks

Someone asks me about peptides most weeks. Usually they have already read a forum thread, already know what they want to run, and are really asking me to sign off on it. This page is what I actually say instead.

There are no doses here, and no protocols. That is deliberate — not because the information is secret, but because a dose written for a stranger on a webpage is worth nothing without knowing their bloodwork, their medicines and their history. What I can give you is the part almost nobody publishes: what is actually in the vial, and what the evidence genuinely shows.

“Peptide” is doing far too much work as a word

A peptide is just a short chain of amino acids. Insulin is a peptide. So is the collagen in your supplement tub. The word tells you about molecular size, and almost nothing about safety, legality or whether it works.

When people say “peptides” in a fitness context, they are usually talking about four very different groups that get discussed as if they were one:

1. Approved prescription drugs with real trial evidence

Semaglutide and tirzepatide sit here. Large randomised trials, known safety profiles, regulatory approval, and a prescriber who monitors you. These work. They also have real side effects and real contraindications, which is exactly why they are prescription-only.

2. Approved hormones with narrow approved uses

Growth hormone is approved — for growth hormone deficiency, certain genetic conditions, and a short list of others. Using it because you want to recover faster at 34 is not one of those indications. It is prescription-only in India and almost everywhere else.

3. Compounds with interesting mechanisms and thin human data

BPC-157 and TB-500 are the obvious examples. The animal literature genuinely is interesting — tendon healing, gut protection, angiogenesis. The human literature is close to non-existent. “Promising in rats” and “proven in people” are separated by roughly a decade and most drug candidates die in the gap.

4. Things being sold as peptides that are not really the point

Melanotan II is a good example of why category matters. It works — it does tan you. It also darkens moles, and there are published case reports of melanoma diagnosed in people using it. A compound doing what it says on the tin is not the same as a compound being safe.

The part nobody wants to talk about: what is in the vial

Set aside every argument about whether a compound works. There is a prior question, and it is the one I care about most as a pharmacist. When you buy a vial labelled “for research use only”, nobody has verified what is inside it.

This is not a hypothetical worry. People have bought these products and put them through a mass spectrometer. The findings are worse than most users assume.

In one analysis of semaglutide bought from online sellers without a prescription, every single sample tested positive for endotoxins — bacterial breakdown products that cause fever and dangerous drops in blood pressure when injected. A forensic analysis of seized falsified peptides found residual industrial solvent in every sample, left over from synthesis.

This is the argument I find people have genuinely not heard. You can hold a confident view on whether a compound is worth using and still be buying something that is 12% of what it claims to be, contaminated with endotoxin, and carrying heavy metals.

Where the law actually sits

In India, growth hormone, testosterone and the GLP-1 drugs are prescription-only — Schedule H. Selling or supplying them without a prescription is not a grey area. Most of the other compounds people ask about are not approved for human use at all, which is a different problem: not banned, just never assessed.

Regulators are actively moving on this. In April 2026 the US FDA removed BPC-157, TB-500 and CJC-1295 from its Category 2 list after their nominations were withdrawn, but did not move them to the approved-for-compounding list. In July 2026 an FDA advisory committee voted narrowly, 8–6, in favour of allowing BPC-157 to be compounded — a non-binding vote still awaiting FDA sign-off.

That is worth reading carefully, because it is routinely misquoted in both directions. It is not approval. It is also not prohibition. It is a regulator openly undecided, which is an honest reflection of how thin the evidence is.

If you are going to do this anyway

People do. Telling someone who has already decided that they simply should not is how you guarantee they stop telling you the truth. So:

• Get bloodwork first, and again after. Not as a formality. A baseline you never took is a comparison you can never make.
• Tell your doctor. Not your coach, not a forum. If something goes wrong, the person treating you needs to know what is on board.
• Know what suppresses you and what does not. Anything that shuts down your own hormone production is a decision with a recovery period attached, and that recovery is not guaranteed.
• One change at a time. Four compounds started together means you learn nothing about any of them, including which one caused the side effect.
• Watch glucose if growth hormone or its secretagogues are involved. Insulin resistance is the predictable consequence, and it is easy to miss without testing.

What I do, and what I will not do

I am a pharmacist and a nutritionist. I read bloodwork, I know how these molecules behave, and I will tell you honestly what the evidence supports and where the risk sits. If you are already using something, I would far rather know about it than be kept in the dark while I write your nutrition around it.

What I will not do is write you a protocol for a prescription drug, tell you where to buy anything, or put my name to doses for someone whose reports I have never seen. That is not caution for its own sake. Prescribing is a doctor’s job, and a coach who blurs that line is a coach you should not trust with anything else either.

Sources

• Multifactor quality and safety analysis of semaglutide sold by online sellers without a prescription (JMIR)
• FDA — Pharmacy Compounding Advisory Committee meeting, July 2026
• FDA advisory committee votes to add BPC-157 to drug compounding list (ABC News)
• Regulatory status of popular compounded peptides

Please read. This page is general information, not medical advice, and not advice about you specifically. It is not a recommendation to use any compound mentioned. Several are prescription-only medicines and several are not approved for human use at all. Nothing here is a reason to start, stop or change a prescribed medicine — that decision belongs to your doctor.